Journal
/
/
Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma
JoVE Journal
Cancer Research
A subscription to JoVE is required to view this content.  Sign in or start your free trial.
JoVE Journal Cancer Research
Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma
DOI:

06:08 min

June 02, 2023

, , , , , , , , ,

Chapters

  • 00:04Introduction
  • 01:03Tumor Transplantation and Preservation
  • 02:49Resuscitation of Patient-Derived Xenograft (PDX) Model Tumors
  • 03:57Results: Tumor Growth Assessment & Effect of Lenvatinib and Cisplatin on PDX Model Tumors
  • 05:28Conclusion

Summary

Automatic Translation

The present protocol establishes and characterizes a patient-derived xenograft (PDX) model of anaplastic thyroid carcinoma (ATC) and head and neck squamous cell carcinoma (HNSCC), as PDX models are rapidly becoming the standard in the field of translational oncology.

Related Videos

Read Article